(Q36743146)

16 August 2017

Acute haemodynamic comparison of amrinone and pirbuterol in chronic heart failure. Additional effects of isosorbide dinitrate (English)

1 reference

16 August 2017

1 reference

chronic heart failure

1 reference

Bayliss J

1

1 reference

16 August 2017

Norell M

2

1 reference

16 August 2017

Canepa-Anson R

3

1 reference

16 August 2017

Reuben SR

4

1 reference

16 August 2017

Poole-Wilson PA

5

1 reference

16 August 2017

Sutton GC

6

1 reference

16 August 2017

1 March 1983

1 reference

16 August 2017

British Heart Journal

1 reference

16 August 2017

49

1 reference

16 August 2017

3

1 reference

16 August 2017

214-221

1 reference

Amrinone and exercise performance in patients with chronic heart failure

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481291

Comparative pharmacology and clinical efficacy of newer agents in treatment of heart failure

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481291

Combined vasodilator and inotropic therapy of heart failure: experimental and clinical concepts

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481291

Treatment of chronic heart failure with pirbuterol: acute haemodynamic responses

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481291

Vasodilator therapy of cardiac failure: (first of two parts)

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481291

Vasodilator treatment for acute and chronic heart failure

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481291

Importance of maintaining systemic blood pressure during nitroglycerin administration for reducing ischemic injury in patients with coronary disease. Effects on coronary blood flow, myocardial energetics and left ventricular function

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481291

Pharmacological mechanisms for left ventricular unloading in clinical congestive heart failure. Differential effects of nitroprusside, phentolamine, and nitroglycerin on cardiac function and peripheral circulation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481291

Effect of dopamine on hemodynamics and myocardial metabolism in shock following acute myocardial infarction in man

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481291

Hemodynamic effects of intravenous and oral amrinone in patients with severe heart failure: relationship between intravenous and oral administration

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481291

Amrinone: a new non-glycosidic, non-adrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in man

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481291

Beneficial effects of amrinone-hydralazine combination on resting hemodynamics and exercise capacity in patients with severe congestive heart failure.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481291

Comparison of hemodynamic actions of pirbuterol and dobutamine on cardiac function in severe congestive heart failure.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481291

Effects of amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481291

Sustained beneficial effects of oral amrinone on cardiac and renal function in patients with severe congestive heart failure.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481291

Problems in assessment of new pharmacologic agents for the heart failure patient

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481291

Usefulness and limitations of the rate of rise of intraventricular pressure (dp-dt) in the evaluation of myocardial contractility in man

5 September 2018

1 reference

12 December 2020

Effect of Isoproterenol, l -Norepinephrine, and Intraaortic Counterpulsation on Hemodynamics and Myocardial Metabolism in Shock following Acute Myocardial Infarction

1 reference

12 December 2020

Comparative hemodynamic effects of inotropic and vasodilator drugs in severe heart failure

1 reference

12 December 2020

Hemodynamic assessment of amrinone. A new inotropic agent

1 reference

12 December 2020

How much can we expect from vasodilator therapy in congestive heart failure?

1 reference

12 December 2020

Thrombocytopenia and fever in a patient taking amrinone

1 reference

12 December 2020

High-performance liquid chromatographic analysis of amrinone and its N-acetyl derivative in plasma. Pharmacokinetics of amrinone in the dog

1 reference

12 December 2020

Oral amrinone in refractory congestive heart failure

1 reference

12 December 2020

Relationship between amrinone plasma concentration and cardiac index

1 reference

12 December 2020

Acute effects of oral pirbuterol on myocardial oxygen metabolism and systemic hemodynamics in chronic congestive heart failure

1 reference

12 December 2020

Single-dose and dose-response studies with oral pirbuterol, a new beta agonist in chronic heart failure

1 reference

12 December 2020

Acute substantial benefit of inotropic therapy with amrinone on exercise hemodynamics and metabolism in severe congestive heart failure

1 reference

12 December 2020

Identifiers

DOI

10.1136/HRT.49.3.214

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

6830658

1 reference